Azar: CMS Would Seek New Ways To Do Drug-Pricing Pilots If ACA Axed

April 05, 2019
HHS Secretary Alex Azar acknowledged Thursday (April 4) that the Center for Medicare and Medicaid Innovation (CMMI) would cease to exist if the Affordable Care Act (ACA) is struck down, but he told lawmakers the department would find new ways to do drug-pricing and other demonstrations that now fall under the innovation center. At a Senate Appropriations health subcommittee hearing on the proposed fiscal 2020 budget, Sen. Tammy Baldwin (D-WI) questioned Azar on what might happen to the international drug...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.